Clinical Trial Update: Safety and Efficacy of Adipose Derived Regenerative Cells (ADRCs) Delivered Via the Intracoronary Route in the Treatment of Patients With ST-elevation Acute Myocardial Infarction (AMI) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing intracoronary delivery of adipose-derived regenerative cells (ADRCs) for ST-elevation myocardial infarction evaluates safety and efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Adipose-Derived Regenerative Cells (ADRCs) (adipose-derived regenerative cells)

Snippet

Sponsor: Cytori Therapeutics | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED